Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

PURPOSE: The aim of this study was to evaluate the efficacy and safety of hormonal and synchronous docetaxel plus prednisone (DocP) in metastatic hormone-sensitive prostate cancer (mHSPC). METHODS: One hundred fifty-one cases with high-burden mHSPC diagnosed at 1 single center from January 2014 to A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Manag Res
Hauptverfasser: Hu, Linjun, Zhao, Qinxin, Bai, Hongsong, Xie, Chengming, Shan, Xingli, Lu, Dehu, Chen, Yonghai, Han, Dongdong, Xiao, Zejun, Tian, Jun, Wang, Dong, Bi, Xingang, Xing, Nianzeng
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293408/
https://ncbi.nlm.nih.gov/pubmed/32606932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S243843
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge